Health, Medicine and Natural Healing 05

567,887 topics in this forum

1. [NATAP] Pioglitazone: heart disease, lipids, diabetes

   By Guest guest, May 31, 2005
   • 0 replies
   • 22 views
   • 
   • Guest
   • May 31, 2005

2. [NATAP] Pioglitazone: heart disease, lipids, diabetes

   By Guest guest, May 31, 2005
   • 0 replies
   • 19 views
   • 
   • Guest
   • May 31, 2005

3. [NATAP] PIs & Heart Disease

   By Guest guest, May 24, 2005
   • 0 replies
   • 23 views
   • 
   • Guest
   • May 24, 2005

4. [NATAP] PIs & Heart Disease

   By Guest guest, May 24, 2005
   • 0 replies
   • 56 views
   • 
   • Guest
   • May 24, 2005

5. [NATAP] PIs & Heart Disease

   By Guest guest, May 24, 2005
   • 0 replies
   • 37 views
   • 
   • Guest
   • May 24, 2005

6. [NATAP] PL-100, New Protease Inhibitor

   By Guest guest, June 10, 2005
   • 0 replies
   • 31 views
   • 
   • Guest
   • June 10, 2005

7. [NATAP] PL-100, New Protease Inhibitor

   By Guest guest, June 10, 2005
   • 0 replies
   • 13 views
   • 
   • Guest
   • June 10, 2005

8. [NATAP] PL-100, New Protease Inhibitor

   By Guest guest, June 10, 2005
   • 0 replies
   • 30 views
   • 
   • Guest
   • June 10, 2005

9. [NATAP] predicting SVR: 12 or 4 week EVR

   By Guest guest, June 6, 2005
   • 0 replies
   • 18 views
   • 
   • Guest
   • June 6, 2005

10. [NATAP] Reduced PI Susceptibility & Secondary Mutations

    By Guest guest, June 16, 2005
    • 0 replies
    • 18 views
    • 
    • Guest
    • June 16, 2005

11. [NATAP] Reduced PI Susceptibility & Secondary Mutations

    By Guest guest, June 16, 2005
    • 0 replies
    • 24 views
    • 
    • Guest
    • June 16, 2005

12. [NATAP] Resistance Testing: Accuracy, Precision, and Consistency

    By Guest guest, June 10, 2005
    • 0 replies
    • 31 views
    • 
    • Guest
    • June 10, 2005

13. [NATAP] Resistance Testing: Accuracy, Precision, and Consistency

    By Guest guest, June 10, 2005
    • 0 replies
    • 20 views
    • 
    • Guest
    • June 10, 2005

14. [NATAP] Resistance Wksp Report- Margolis, MD

    By Guest guest, July 6, 2005
    • 0 replies
    • 18 views
    • 
    • Guest
    • July 6, 2005

15. [NATAP] Resistance Wksp Report- Margolis, MD

    By Guest guest, July 6, 2005
    • 0 replies
    • 22 views
    • 
    • Guest
    • July 6, 2005

16. [NATAP] Reyataz Predicting Outcome: PK, Muations, Pheno Cutoff

    By Guest guest, June 12, 2005
    • 0 replies
    • 24 views
    • 
    • Guest
    • June 12, 2005

17. [NATAP] Reyataz Predicting Outcome: PK, Muations, Pheno Cutoff

    By Guest guest, June 12, 2005
    • 0 replies
    • 13 views
    • 
    • Guest
    • June 12, 2005

18. [NATAP] Reyataz Predicting Outcome: PK, Muations, Pheno Cutoff

    By Guest guest, June 12, 2005
    • 0 replies
    • 35 views
    • 
    • Guest
    • June 12, 2005

19. [NATAP] Reyataz/r + TDF: safety & efficacy

    By Guest guest, August 7, 2005
    • 0 replies
    • 18 views
    • 
    • Guest
    • August 7, 2005

20. [NATAP] Risk factors: CD4 Decrease & TDF/DDI

    By Guest guest, June 20, 2005
    • 0 replies
    • 88 views
    • 
    • Guest
    • June 20, 2005

21. [NATAP] Risk factors: CD4 Decrease & TDF/DDI

    By Guest guest, June 20, 2005
    • 0 replies
    • 22 views
    • 
    • Guest
    • June 20, 2005

22. [NATAP] Schering CCR5 Inhibitor 417690

    By Guest guest, June 9, 2005
    • 0 replies
    • 18 views
    • 
    • Guest
    • June 9, 2005

23. [NATAP] Schering CCR5 Inhibitor 417690

    By Guest guest, June 9, 2005
    • 0 replies
    • 21 views
    • 
    • Guest
    • June 9, 2005

24. [NATAP] Schering CCR5 Inhibitor 417690

    By Guest guest, June 9, 2005
    • 0 replies
    • 20 views
    • 
    • Guest
    • June 9, 2005

25. [NATAP] Schering CCR5 Inhibitor 417690

    By Guest guest, June 9, 2005
    • 0 replies
    • 22 views
    • 
    • Guest
    • June 9, 2005